Publications
Click on a title to open the PDF. You will need Adobe Acrobat Reader installed on your computer to view the PDF files. If you do not have Adobe Acrobat Reader, you can download it from here.| 61 |
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. |
|
| Francis CY, Morris J, Whorwell PJ. | Alimentary Pharmacology and Therapeutics 1997;11:395-402. | |
| 62 |
High prevalence of irritable bowel syndrome in patients attending urological outpatient departments. |
|
| Francis CY, Duffy JN, Whorwell PJ. Morris J. | Digestive Diseases and Sciences 1997;42:404-7. | |
| 63 | The role of fibre in irritable bowel syndrome. | |
| Hammonds R, Whorwell PJ. | Int J Gastroenterology 1997;2:9-12. | |
| 64 |
Zamifenacin (UK-76,654), a potent gut M 3 selective muscarinic antagonist reduces colonic motor activity in patients with irritable bowel syndrome. |
|
| Houghton LA, Rodgers J, Whorwell PJ, Campbell FC, Williams NS, Goka J. |
Alimentary Pharmacology and Therapeutics 1997;11:561-8. | |
| 65 | Opening the doors of perception in the irritable bowel syndrome. | |
| Houghton LA, Whorwell PJ. | Gut 1997;41:567-8. | |
| 66 | Neurophysiology and neuropsychiatry of the irritable bowel syndrome. | |
| Dapoigny M, Coremans G, Jule Y, Muller-Lissner SA, Pace F, Smout A, Stockbrugger RW, Whorwell PJ. |
Digestion 1997;58:1-9. | |
| 67 | Motility in irritable bowel syndrome. | |
| Muller-Lissner SA, Coremans G, Dapoigny M, Pace F, Smout A, Stockbrugger RW, Tougas G, Whorwell PJ, Wienbeck M. |
Digestion 1997;58:196-202. | |
| 68 | Getting to grips with constipation. | |
| Whorwell PJ. | Health and Ageing 1997;31-3. | |
| 69 | Undertaking therapeutic trials in irritable bowel syndrome in the primary care setting. | |
| Whorwell PJ, Coremans G, Dapoigny M, Jones R, Muller-Lissner SA, Muris J, Smouth A, Stockbrugger RW, Pace F. |
European Journal of General Practice 1997; 3:149-51. |
|
| 70 | Clinical economics review: irritable bowel syndrome. | |
| Wells NEJ, Hahn BA, Whorwell PJ. | Alimentary Pharmacology and Therapeutics 1997;11:1019-30. | |
| 71 |
Efficacy and safety of the peripheral kappa agonist fedotizine versus placebo in the treatment of functional dyspepsia. | |
| Read NW, Abitbol JL, Bardham KD, Whorwell PJ, Fraitag B. |
Gut 1997;41:664-8. | |
| 72 | Chlamydia trachomatis infection: is it relevant in irritable bowel syndrome? | |
| Francis CY, Prior A, Whorwell PJ. | Digestion 1998;59:157-9. | |
| 73 | Bran: may irritate irritable bowel. | |
| Lewis MJV, Whorwell PJ. | Nutrition 1998 ;14:470-1. | |
| 74 | Physiological and psychological aspects of IBS and the role of hypnosis. | |
| Gonsalkorale W, Houghton LA, Whorwell PJ. | Gastroenterology International 1998;11:36-44. | |
| 75 | Psychosocial background and intervention in the irritable bowel syndrome. | |
| Stockbrugger RW, Coremans G, Creed F, Dapoigny M, Muller-Lissner SA, Pace F, Smouth A, Whorwell PJ. |
Digestion 1999;60:175-86. | |